Advertisement
UK markets close in 22 minutes

  • FTSE 100

    8,039.36
    -5.45 (-0.07%)
     

  • FTSE 250

    19,713.38
    -86.34 (-0.44%)
     

  • AIM

    754.55
    -0.32 (-0.04%)
     

  • GBP/EUR

    1.1634
    +0.0006 (+0.05%)
     

  • GBP/USD

    1.2438
    -0.0015 (-0.12%)
     

  • Bitcoin GBP

    52,317.87
    -1,389.84 (-2.59%)
     

  • CMC Crypto 200

    1,409.52
    -14.58 (-1.02%)
     

  • S&P 500

    5,058.88
    -11.67 (-0.23%)
     

  • DOW

    38,364.54
    -139.15 (-0.36%)
     

  • CRUDE OIL

    82.80
    -0.56 (-0.67%)
     

  • GOLD FUTURES

    2,342.80
    +0.70 (+0.03%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,076.65
    -61.00 (-0.34%)
     

  • CAC 40

    8,082.01
    -23.77 (-0.29%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Smith & Nephew buys Russian manufacturing business

Reuters - UK Focus

LONDON, July 10 (Reuters) - British artificial hip and knee maker Smith & Nephew (LSE: SN.L - news) said it had bought a Russian distribution and manufacturing business, in line with its strategy of expanding in emerging markets.

Smith & Nephew said on Friday it was adding the trauma and orthopaedics unit of Russian company DeOst to boost its local presence for an undisclosed sum. The deal involved adding 350 new employees.

Sanctions imposed on Russia by the United States and Europe in response to Moscow's part in the Ukraine crisis have complicated life for some European firms doing business in Russia.

DeOst has distributed Smith & Nephew's products in Russia since 2009, the British company said.

"(Its) local capability to manufacture mid-tier trauma products will enable us to reach more customers following recent changes relating to state tenders supporting Russian produced products," Smith & Nephew said in its statement. (Reporting by Sarah Young; editing by Kate Holton)